CDXS Codexis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDXS

Price (delayed)

$3.88

Market cap

$255.87M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.51

Enterprise value

$183.49M

Highlights
CDXS's revenue is up by 32% year-on-year and by 4.4% since the previous quarter
Codexis's gross profit has increased by 22% YoY and by 4.4% QoQ
The company's net income has shrunk by 58% YoY and by 8% QoQ
The EPS has dropped by 55% year-on-year and by 6% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.cedexis.com/
Peers: BCPC MRK PFE DD

Key stats

What are the main financial stats of CDXS
Market
Shares outstanding
65.95M
Market cap
$255.87M
Enterprise value
$183.49M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.76
Price to sales (P/S)
1.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.32
Earnings
Revenue
$138.59M
EBIT
-$33.32M
EBITDA
-$23.07M
Free cash flow
$3.01M
Per share
EPS
-$0.51
Free cash flow per share
$0.05
Book value per share
$2.2
Revenue per share
$2.12
TBVPS
$3.78
Balance sheet
Total assets
$250.39M
Total liabilities
$105.6M
Debt
$43.64M
Equity
$144.8M
Working capital
$113.83M
Liquidity
Debt to equity
0.3
Current ratio
3.32
Quick ratio
3.15
Net debt/EBITDA
3.14
Margins
EBITDA margin
-16.6%
Gross margin
72.6%
Net margin
-24.2%
Operating margin
-25.2%
Efficiency
Return on assets
-14.1%
Return on equity
-21.8%
Return on invested capital
-23.4%
Return on capital employed
-16.5%
Return on sales
-24%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDXS stock price

How has the Codexis stock price performed over time
Intraday
0.26%
1 week
-0.26%
1 month
-17.97%
1 year
-81.04%
YTD
-16.74%
QTD
-16.74%

Financial performance

How have Codexis's revenue and profit performed over time
Revenue
$138.59M
Gross profit
$100.56M
Operating income
-$34.88M
Net income
-$33.59M
Gross margin
72.6%
Net margin
-24.2%
The company's net income has shrunk by 58% YoY and by 8% QoQ
The company's operating income has shrunk by 54% YoY and by 9% QoQ
CDXS's revenue is up by 32% year-on-year and by 4.4% since the previous quarter
Codexis's gross profit has increased by 22% YoY and by 4.4% QoQ

Growth

What is Codexis's growth rate over time

Valuation

What is Codexis stock price valuation
P/E
N/A
P/B
1.76
P/S
1.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.32
The EPS has dropped by 55% year-on-year and by 6% since the previous quarter
CDXS's price to book (P/B) is 84% lower than its 5-year quarterly average of 10.8 and 60% lower than its last 4 quarters average of 4.4
The equity has declined by 12% year-on-year and by 6% since the previous quarter
The price to sales (P/S) is 85% lower than the 5-year quarterly average of 12.6 and 65% lower than the last 4 quarters average of 5.3
CDXS's revenue is up by 32% year-on-year and by 4.4% since the previous quarter

Efficiency

How efficient is Codexis business performance
Codexis's return on equity has shrunk by 69% YoY and by 11% QoQ
Codexis's return on assets has decreased by 48% YoY and by 8% QoQ
The return on sales has declined by 19% year-on-year and by 3% since the previous quarter
The company's return on invested capital fell by 10% QoQ and by 4.5% YoY

Dividends

What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDXS.

Financial health

How did Codexis financials performed over time
CDXS's total assets is 137% greater than its total liabilities
Codexis's current ratio has decreased by 32% YoY and by 28% QoQ
CDXS's quick ratio is down by 31% year-on-year and by 25% since the previous quarter
The debt is 70% less than the equity
The equity has declined by 12% year-on-year and by 6% since the previous quarter
The debt has contracted by 8% YoY and by 2.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.